Oliver S - Search Results

1

Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer.

Ranson M, Wilson RH, O'Sullivan JM, Maruoka M, Yamaguchi A, Cowan RA, Logue JP, Tomkinson H, Tominaga N, Swaisland H, Oliver S, Usami M. Ranson M, et al. Among authors: oliver s. Int J Clin Pharmacol Ther. 2010 Nov;48(11):708-17. doi: 10.5414/cpp48708. Int J Clin Pharmacol Ther. 2010. PMID: 20979929

2

An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteers.

Tomkinson HK, Kemp JV, Wollseifen T, Morris T, Oliver SD. Tomkinson HK, et al. Clin Ther. 2010 Jul;32(7):1372-86. doi: 10.1016/j.clinthera.2010.07.013. Clin Ther. 2010. PMID: 20678684 Clinical Trial.

3

Disposition and metabolism of the specific endothelin A receptor antagonist zibotentan (ZD4054) in healthy volunteers.

Clarkson-Jones JA, Kenyon AS, Kemp J, Lenz EM, Oliver SD, Swaisland H. Clarkson-Jones JA, et al. Among authors: oliver sd. Xenobiotica. 2012 Apr;42(4):363-71. doi: 10.3109/00498254.2011.624204. Epub 2011 Oct 20. Xenobiotica. 2012. PMID: 22014279

4

Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies.

Tomkinson H, Kemp J, Oliver S, Swaisland H, Taboada M, Morris T. Tomkinson H, et al. Among authors: oliver s. BMC Clin Pharmacol. 2011 Mar 17;11:3. doi: 10.1186/1472-6904-11-3. BMC Clin Pharmacol. 2011. PMID: 21414193 Free PMC article. Clinical Trial.

5

Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study.

Saunders MP, Wilson R, Peeters M, Smith R, Godwood A, Oliver S, Van Cutsem E. Saunders MP, et al. Among authors: oliver s. Cancer Chemother Pharmacol. 2009 Sep;64(4):665-72. doi: 10.1007/s00280-008-0914-4. Epub 2009 Jan 29. Cancer Chemother Pharmacol. 2009. PMID: 19184020 Clinical Trial.

6

In vitro metabolism of the specific endothelin-A receptor antagonist ZD4054 and clinical drug interactions between ZD4054 and rifampicin or itraconazole in healthy male volunteers.

Swaisland HC, Oliver SD, Morris T, Jones HK, Bakhtyari A, Mackey A, McCormick AD, Slamon D, Hargreaves JA, Millar A, Taboada MT. Swaisland HC, et al. Among authors: oliver sd. Xenobiotica. 2009 Jun;39(6):444-56. doi: 10.1080/00498250902810944. Xenobiotica. 2009. PMID: 19480550 Clinical Trial.

7

Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia.

Dennis M, Davies M, Oliver S, D'Souza R, Pike L, Stockman P. Dennis M, et al. Among authors: oliver s. Cancer Chemother Pharmacol. 2012 Sep;70(3):461-9. doi: 10.1007/s00280-012-1939-2. Epub 2012 Aug 4. Cancer Chemother Pharmacol. 2012. PMID: 22864876 Free PMC article. Clinical Trial.

8

Pharmacokinetics of vandetanib: three phase I studies in healthy subjects.

Martin P, Oliver S, Kennedy SJ, Partridge E, Hutchison M, Clarke D, Giles P. Martin P, et al. Among authors: oliver s. Clin Ther. 2012 Jan;34(1):221-37. doi: 10.1016/j.clinthera.2011.11.011. Epub 2011 Dec 28. Clin Ther. 2012. PMID: 22206795 Clinical Trial.

9

Pharmacokinetic Properties of Fostamatinib in Patients With Renal or Hepatic Impairment: Results From 2 Phase I Clinical Studies.

Martin P, Oliver S, Gillen M, Marbury T, Millson D. Martin P, et al. Among authors: oliver s. Clin Ther. 2015 Dec 1;37(12):2823-36. doi: 10.1016/j.clinthera.2015.09.016. Epub 2015 Oct 27. Clin Ther. 2015. PMID: 26519231 Clinical Trial.

10

A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects.

Han K, Cremer J, Elston R, Oliver S, Baptiste-Brown S, Chen S, Gardiner D, Davies M, Saunders J, Hamatake R, Losos J, Leivers M, Hood S, van der Berg F, Paff M, Ritter JM, Theodore D. Han K, et al. Among authors: oliver s. Clin Pharmacol Drug Dev. 2019 Aug;8(6):790-801. doi: 10.1002/cpdd.670. Epub 2019 Mar 12. Clin Pharmacol Drug Dev. 2019. PMID: 30861337 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,559 results

Search Page

Filters